The Skin Cancer Foundation Journal

MAY 2013

The 2012 edition of The Skin Cancer Foundation Journal features medically reviewed, reader-friendly articles such as tanning, the increasing incidence of skin cancer diagnoses among young women, & the prevalence of melanoma among white males over 50.

Issue link:

Contents of this Issue


Page 64 of 103

1 A B 2 Figure 1 (top left): Two melanomas. (a) This melanoma discovered at an early stage is small in diameter and resembles a benign mole. (b) This melanoma has grown and now possesses the classic ABCD criteria. Figure 2 (bottom left): Two different colors are presented unevenly within the same lesion. This lesion would be considered "asymmetric" (uneven) in the distribution of color and textures, but is oval and symmetric in contour. Figure 3 (top right): Two melanomas that don't adhere to the ABCDEs. (a) Amelanotic melanoma — a solitary In the ever-expanding armory of melanoma diagnostic methods, these simple visual techniques are playing an important role. Used alone, in combination, or in conjunction with tools such as dermoscopy, the ABCDEs, the EFG rule, the Ugly Duckling, and the Blue-Black rule should lead to earlier detection of melanoma by both patients and physicians, significantly decreasing deaths from the disease. 3 A B 4 pink lesion lacking the classic ABCDE criteria; these are often detected with the "ugly duckling" sign or because of change. (b) Nodular melanoma showing a blue-black hue with symmetrical contour but displaying unevenness in the distribution of the blue hue; it thus would be classifed as asymmetrical in content. Figure 4 (bottom right): The back of a patient with multiple moles. The outlier dark brown lesion to the left of the midline is a melanoma, demonstrating the utility of the "ugly duckling" sign. aShFaQ MaRGhooB, MD, is Clinical Associate Professor, Dermatology Service, Memorial Sloan-Kettering Cancer Center in New York City. Dr. Marghoob specializes in the early detection of skin cancer. His research focuses on evaluating morphologic features to help differentiate nevi from melanoma. Dr. Marghoob is Associate Editor of The Skin Cancer Foundation's quarterly clinical publication, The Melanoma Letter. SaRah yaGeRMan is a Clinical Research Fellow in Dermatology at Memorial Sloan-Kettering Cancer Center. She completed her Bachelor of Science in Biological and Environmental Engineering in 2008 at Cornell University and currently attends Weill Cornell Medical College. References available on p.94. 63

Articles in this issue

Archives of this issue

view archives of The Skin Cancer Foundation Journal - MAY 2013